Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
American Journal of Epidemiology|February 7, 2001
Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?Z Guo, L Fratiglioni, M Viitanen, et al.Psychological Medicine|July 12, 2013
Cognitive deficits in unipolar old-age depression: a population-based studyA Pantzar, E J Laukka, A R Atti, et al.Brain Research|October 21, 1996
Impaired G-protein-stimulated adenylyl cyclase activity in Alzheimer's disease brain is not accompanied by reduced cyclic-AMP-dependent protein kinase A activityW L Bonkale, J Fastbom, B Wiehager, et al.Scandinavian Journal of Primary Health Care|August 24, 2017
Pay for performance associated with increased volume of medication reviews but not with less inappropriate use of medications among the elderly - an observational studyH Ödesjö, A Anell, A Boman, et al.Journal of the American Geriatrics Society|April 13, 2001
The appropriateness of drug use in an older nondemented and demented populationM S Giron, H X Wang, C Bernsten, et al.Brain Research|January 12, 2000
Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid depositsA García-Jiménez, R F Cowburn, T G Ohm, et al.Clinical Drug Investigation|January 1, 1997
: prevalence and association with drug useC Cornelius, J Fastbom, C B Claesson, et al.The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|September 14, 2000
The relationship between signs of cardiovascular deficiency and cognitive performance in old age: a population-based studyK Fahlander, A Wahlin, J Fastbom, et al.Brain Research|August 5, 1998
Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathologyT Kurumatani, J Fastbom, W L Bonkale, et al.Neuroscience|July 17, 1999
Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologiesM Kelliher, J Fastbom, R F Cowburn, et al.Pageof 6